1) The UKPDS trial compared intensive blood glucose control using sulfonylureas or insulin to conventional treatment in over 3,800 patients with newly diagnosed type 2 diabetes over 10 years. 2) Intensive treatment lowered A1C more but did not reduce macrovascular complications like heart disease. It did reduce microvascular complications like eye and kidney disease. 3) Intensive treatment was associated with more hypoglycemia.